Boothbay Fund Management’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $452K | Sell |
40,084
-97,801
| -71% | -$1.1M | 0.01% | 762 |
|
|
2025
Q1 | $1.39M | Buy |
137,885
+110,271
| +399% | +$1.11M | 0.04% | 412 |
|
|
2024
Q4 | $327K | Sell |
27,614
-103
| -0.4% | -$1.22K | 0.01% | 891 |
|
|
2024
Q3 | $320K | Hold |
27,717
| – | – | 0.01% | 1012 |
|
|
2024
Q2 | $293K | Hold |
27,717
| – | – | 0.01% | 1020 |
|
|
2024
Q1 | $292K | Sell |
27,717
-8,795
| -24% | -$92.7K | 0.01% | 1039 |
|
|
2023
Q4 | $410K | Buy |
+36,512
| New | +$410K | 0.01% | 916 |
|
|
2023
Q3 | – | Sell |
-45,158
| Closed | -$455K | – | 1788 |
|
|
2023
Q2 | $455K | Sell |
45,158
-97,944
| -68% | -$987K | 0.01% | 961 |
|
|
2023
Q1 | $1.06M | Buy |
+143,102
| New | +$1.06M | 0.02% | 801 |
|